Latest from IMDS
TCT 2026
IMDS will be exhibiting at TCT 2026, the leading global meeting for interventional cardiovascular medicine, held October 31 to November 3 at the San Diego Convention Center.
The congress marks the US launch of NHanceIT, our single-lumen microcatheter. Stop by booth #3218 to see NHanceIT first-hand, explore our wider portfolio, and meet our team. We look forward to seeing you in San Diego!
NHanceIT Launch in the U.S.
IMDS is announcing the U.S. launch of NHanceIT, a new single-lumen microcatheter engineered to outmaneuver complexity and better support CTO & CHIP operators when performance matters most. NHanceIT is the company’s third product to feature its proprietary Skeleton Backbone Technology, a structural advancement in catheter reinforcement.
CVI 2026
IMDS was present at CVI 2026. Jai Khatri, MD delivered a standout podium presentation, “CROSS & CRACK: Crossing and Calcium Prep in the Calcified CHIP,” to a packed room at the Exhibit Hall. Thank you, Dr. Khatri, for sharing such valuable insight into calcified CHIP management — and to SIS Medical and RADPAD® Radiation Protection for co-sponsoring the session alongside us.
Showcasing our portfolio through live product demos and spotlighting the Skeleton Backbone Technology™ – a structural breakthrough in performance, engineered to expand what’s possible in PCI CTO intervention.
Groningen Volleyball Tournament
The IMDS crew hit the courts in Groningen for the annual volleyball tournament, and let’s just say the competitive spirit was very much alive. Events like these remind us why culture matters just as much as the work we do. Building trust and having a great time together — that’s what makes IMDS more than just a workplace.
ReCross Dual Lumen OTW | Ashish Pershad, MD, MS
Versatility of ReCross: ADR in a Post-CABG Native RCA, Chronic Total Occlusion. A case by Ashish Pershad, MD, MS., from Chandler Regional Medical Center – Dignity Health. ReCross is a dual-lumen, over-the-wire microcatheter, part of the IMDS product portfolio.
New FlowGuide7F case demonstrates effects over pressure dampening
Case led by Dr. Gregor Leibundgut – A symptomatic 77-year-old female patient was treated for left coronary artery disease (CAD) in the left anterior descending artery (LAD). The LAD demonstrated significant tortuosity, and therefore a 6F Guideliner was selected to improve guide support.
